Grabels, France

Suzanne Peyrottes


 

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 175(Granted Patents)


Company Filing History:


Years Active: 2011-2022

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Suzanne Peyrottes: Innovator in Medicinal Chemistry

Introduction

Suzanne Peyrottes is a prominent inventor based in Grabels, France, known for her significant contributions to the field of medicinal chemistry. With a total of seven patents to her name, she has made remarkable advancements in the development of pharmaceutical compounds.

Latest Patents

One of her latest patents is focused on acylnucleoside phosphonates, prodrugs thereof, and their use as medicaments. This invention provides chemical compounds belonging to the group of nucleotide analogues, specifically acylnucleoside phosphonate compounds. The patent details their method of preparation and their application in preventing and treating diseases caused by organisms that are auxotrophic for purines. Additionally, she has developed pharmaceutical compositions containing such compounds. Another notable patent involves 5'-nucleotidase inhibitors and their therapeutic uses. This invention centers around compounds with a 6-aminopurine backbone, which are intended for use in cancer treatment.

Career Highlights

Throughout her career, Suzanne Peyrottes has worked with esteemed organizations such as Idenix Pharmaceuticals, Inc. and the Centre National De La Recherche Scientifique. Her work has significantly impacted the pharmaceutical industry, particularly in the development of innovative treatments.

Collaborations

She has collaborated with notable colleagues, including Christian Perigaud and Jean-Pierre Sommadossi, contributing to her success in the field.

Conclusion

Suzanne Peyrottes stands out as a leading inventor in medicinal chemistry, with her patents paving the way for new therapeutic options. Her dedication to innovation continues to influence the medical field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…